THE EXPERIENCE OF PATIENTS LIVING WITH AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Introduction: Different research presents the implantable cardioverter defibrillator (ICD) as an effective technology for patients with heart disease. In Kazakhstan ICD, implements last ten decades.
The aim of our research is to study the experience of patients after ICD implantation.
Materials and methods: We search documents related to the provision of care to patients with an implantable cardioverter defibrillator. Our cross sectional study included a survey of patients with ICD.The questionnaire consisted of the following parts: demographic data; availability and complexity of medical care in healthcare organizations; the attitude of medical professionals; satisfaction and preferences of respondents with the information received about the ICD. 63 respondents involved in online survey, which conducted in Russian and Kazakh languages, depending on the preferences of the respondents. The survey was conducted among patients who received an ICD in Almaty and Kyzylorda region in February - May 2021. Statistical analysis provided by using the SPSS 13. The variables are presented as the median Me [Q1, Q3]. The analysis of frequency characteristics of qualitative indicators was carried out using non-parametric methods using the Pearson criterion (χ2). Differences in the data were considered statistically significant at p <0.05.
Results: Positive dynamics that the clinical protocol has been developed for healthcare professionals. Outpatient difficulties were associated with an inconvenient system of registration, observation by a cardiologist on a paid basis 36.5%. The satisfaction of the respondents with the attitude of the medical specialists in outpatient and inpatient was high; with given information about ICD lower by respondents with higher education and satisfaction by age revealed that respondents under 60 had a high variation. One third of respondents does not prefer or do not know their preference for the exercise tolerance test and preferred the consultation of a psychologist during hospitalization for implantation.
Conclusion: There are needs to improve the provision of information on the positive and potential negative effects of ICD technology, and the provision of advice to patients at the primary care level, in order to improve the satisfaction and quality of life of patients with ICD
Temirkhan Begisbayev 1, https://orcid.org/0000-0001-7536-3947
Lyazzat Kosherbayeva2,3, https://orcid.org/0000-0001-8376-4345
Marzhan Brimzhanova1, https://orcid.org/0000-0003-3517-4687
Valikhan Akhmetov1, https://orcid.org/0000-0003-4462-4504
Dmitry Khvan4, https://orcid.org/0000-0002-5925-2275
Nazgul Akhtaeva2, https://orcid.org/0000-0002-0835-9814
1 Kazakhstans Medical University "KSPH", Almaty, Republic of Kazakhstan;
2 Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan;
3Al-Farabi Kazakh National University, Almaty, Republic of Kazakhstan;
4 National Medical Research Center named after Academician E. Meshalkin, Ministry of Health of the Russian Federation, Novosibirsk, Russian Federation.
1. Alturki A., Proietti R., Alturki H., Essebag V., Huynh T. Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis // Hellenic J Cardiol. 2019 Sep-Oct., 60(5):276-281. doi: 10.1016/j.hjc.2017.12.003. Epub 2017 Dec 29.
2. Alswyan A.H., Liberato A.C.S., Dougherty C.M. A Systematic Review of Exercise Training in Patients with Cardiac Implantable Devices // J Cardiopulm Rehabil Prev. 2018 Mar., 38(2): 70-84. doi: 10.1097/HCR.0000000000000289.
3. Borne R.T., Varosy P.D., Masoudi F.A. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches // JAMA Intern Med. 2013 May 27. 173(10):859-65. doi: 10.1001/jamainternmed.2013.428.
4. Carroll S.L., Strachan P.H., de Laat S., Schwartz L., Arthur H.M. Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death // Health Expect. 2013 Mar., 16(1):69-79. doi: 10.1111/j.1369-7625.2011.00703.x. Epub 2011 Jun 7.
5. da Silva K.R., Costa R., Rodrigues C.G., Schasechter A., Nobre M.C., Passman R., Mark D.B. Quality of life in patients with implantable cardioverter-defibrillator: systematic review of randomized controlled trials // Eur J Cardiovasc Nurs. 2018. Mar., 17(3):196-206. doi: 10.1177/1474515117739619. Epub 2017 Oct 25. PMID: 29067836.
6. Dickerson S.S. Technology-patient interactions: Internet use for gaining a healthy context for living with an implantable cardioverter defibrillator // Heart Lung. 2005. 34(3): 157–168
7. Goldenberg I., Huang D.T., Nielsen J.C. The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome // Eur Heart J. 2020 Jun 1, 41(21):2003-2011. doi: 10.1093/eurheartj/ehz788.
8. Haugaa K.H., Tilz R., Boveda S., Dobreanu D., Sciaraffia E., Mansourati J., Papiashvili G., Dagres N. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey // Europace. 2017 Apr 1. 19(4):660-664. doi: 10.1093/europace/eux089.
9. Hauptman P.J., Chibnall J.T., Guild C., Armbrecht E.S. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator // JAMA Intern Med. 2013 Apr 8. 173(7):571-7. doi: 10.1001/jamainternmed.2013.3171. PMID: 23420455. -20
10. Hoogwegt M.T., Widdershoven J.W., Theuns D.A., Pedersen S.S. Information provision, satisfaction and emotional distress in patients with an implantable cardioverter-defibrillator // Int J Cardiol. 2014 Dec 15, 177(2):586-8. doi: 10.1016/j.ijcard.2014.08.150. Epub 2014 Aug 30. PMID: 25220174.
11. Jens B. Johansen, Peter T. Mortensen, Regitze Videbæk, Sam Riahi, Mogens Møller, Jens Haarbo, Susanne S. Pedersen, Attitudes towards implantable cardioverter-defibrillator therapy: a national survey in Danish health-care professionals // EP Europace, Volume 13, Issue 5, May 2011, Pages 663–667, https://doi.org/10.1093/europace/euq404
12. Kipp R., Hsu J.C., Freeman J., Curtis J., Bao H., Hoffmayer K.S. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry // Heart Rhythm. 2018 Jun, 15(6):847-854. doi: 10.1016/j.hrthm.2017.09.043. Epub 2017 Oct 5. PMID: 28987459.
13. Kusumoto F.M., Bailey K.R., Chaouki A.S., Deshmukh A.J., Gautam S., Kim R.J., Kramer D.B., et al. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society // J Am Coll Cardiol. 2018 Oct 2, 72(14):1653-1676. doi: 10.1016/j.jacc.2017.10.052. Epub 2017 Oct 30. Erratum in: J Am Coll Cardiol. 2018 Oct 2, 72(14):1756.
14. Li Y., Gong W., Kong X., Mueller O., Lu G. Factors Associated with Outpatient Satisfaction in Tertiary Hospitals in China: A Systematic Review // Int J Environ Res Public Health. 2020 Sep 27, 17(19):7070. doi: 10.3390/ijerph17197070. PMID: 32992600; PMCID: PMC7579147.
15. Pandey A., Parashar A., Moore C., Ngo C., Salahuddin U., Bhargava M., Kumbhani D.J., Piccini J.P., Fonarow G.C., Berry J.D. Safety and Efficacy of Exercise Training in Patients with an Implantable Cardioverter-Defibrillator: A Meta-Analysis // JACC Clin Electrophysiol. 2017 Feb, 3(2):117-126. doi: 10.1016/j.jacep.2016.06.008. Epub 2016 Sep 7. PMID: 29759383.
16. Pedersen S.S., Knudsen C., Dilling K., Sandgaard N.C.F., Johansen J.B. Living with an implantable cardioverter defibrillator: patients' preferences and needs for information provision and care options // Europace. 2017 Jun 1, 19(6):983-990. doi: 10.1093/europace/euw109.
17. Pedersen S.S., Chaitsing R., Szili-Torok T., Jordaens L., Theuns D.A. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life. Am J Cardiol. 2013 May 15, 111(10):1443-7. doi: 10.1016/j.amjcard.2013.01.296. Epub 2013 Mar 12.
18. Saour B., Kaplan R., Ward A., Churyla A., Kim S., Knight B. Management of S-ICD lead in a patient requiring sternotomy. Clin Case Rep. 2019 May 22, 7(7):1309-1311. doi: 10.1002/ccr3.2136.
19. Serber E., Finch N., Leman R., et al. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators // Pacing Clin Electrophysiol. 2009, 32(3):383–390.
20. Sherazi S., Zareba W., Daubert J.P., McNitt S., Shah A.H., Aktas M.K., Block R.C. Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators // Cardiol J. 2010, 17(3):267-73.
21. Stefanovska V.V., Petkovska M.S. Patient satisfaction in outpatient healthcare services at secondary level vs. tertiary level // Srp Arh Celok Lek. 2014 Sep-Oct, 142(9-10):579-85. doi: 10.2298/sarh1410579v. PMID: 25518537. -25
22. Strachan P.H., de Laat S., Carroll S.L., et al. Readability and content of patient education material related to implantable cardioverter defibrillators // J Cardiovasc Nurs. 2012, 27(6):495-504. doi:10.1097/JCN.0b013e31822ad3dd
23. Vakil K., Kazmirczak F., Sathnur N., Adabag S., Cantillon D.J., Kiehl E.L., Koene R., Cogswell R., Anand I., Roukoz H. Implantable Cardioverter-Defibrillator Use in Patients with Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis // JACC Heart Fail. 2016 Oct, 4(10):772-779. doi: 10.1016/j.jchf.2016.05.003. Epub 2016 Jul 6.
24. Vogt A. Establishing an ICD support group // Adv Nurse Pract. 2006, 14(9):59–60.
25. Wallace B.C., Allen L.A., Knoepke C.E., Glasgow R.E., Lewis C.L., Fairclough D.L., Helmkamp L.J., Fitzgerald M.D., Tzou W.S., Kramer D.B., Varosy P.D., Gupta S.K., Mandrola J.M., Brancato S.C., Peterson P.N., Matlock D.D. A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data // Am Heart J. 2020 Aug, 226:161-173. doi: 10.1016/j.ahj.2020.04.010. Epub 2020 Apr 20.
26. Zeitler E.P., Friedman D.J., Loring Z., et al. Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE // Heart Rhythm. 2020, 17(3):447-454. doi:10.1016/j.hrthm.2019.09.024
Количество просмотров: 341
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Begisbayev T., Kosherbayeva L., Brimzhanova M., Akhmetov V., Khvan D., Akhtaeva N. The experience of patients living with an implantable cardioverter defibrillator // Nauka i Zdravookhranenie [Science & Healthcare]. 2021, (Vol.23) 6, pp. 103-110. doi 10.34689/SH.2021.23.6.012Похожие публикации:
МЕХАНИКАЛЫҚ САРҒАЮ ОПЕРАЦИЯСЫ КЕЗІНДЕ КОАГУЛОПАТИЯЛЫҚ ҚАН КЕТУДІҢ АЛДЫН АЛУ ӘДІСІ
ОПТИМИЗАЦИЯ РЕЗУЛЬТАТОВ АУТОДЕРМОПЛАСТИКИ ПРИ ЛЕЧЕНИИ ГРАНУЛИРУЮЩИХ ГНОЙНЫХ РАН
BASICS OF REHABILITATION OF CHILDREN AFTER OPERATIONS ON THE COLON AND ANORECTAL AREA
HEALTH INDICATORS OF FIRST-YEAR-OF-LIFE CHILDREN IN THE REPUBLIC OF KAZAKHSTAN FOR 2013-2022
ОЦЕНКА УДОВЛЕТВОРЕННОСТИ ТРУДОВОЙ ДЕЯТЕЛЬНОСТЬЮ ВРАЧЕЙ АНЕСТЕЗИОЛОГОВ-РЕАНИМАТОЛОГОВ ГОРОДА АСТАНА